Literature DB >> 35291597

Cordycepin from Medicinal Fungi Cordyceps militaris Mitigates Inflammaging-Associated Testicular Damage via Regulating NF-κB/MAPKs Signaling in Naturally Aged Rats.

Spandana Rajendra Kopalli1, Kyu-Min Cha2, Jae Youl Cho3, Si-Kwan Kim4, Sushruta Koppula4.   

Abstract

Inflammaging in male reproductive organs covers a wide variety of problems, including sexual dysfunction and infertility. In this study, the beneficial effects of cordycepin (COR), isolated from potential medicinal fungi Cordyceps militaris, in aging-associated testicular inflammation and serum biochemical changes in naturally aged rats were investigated. Male Sprague Dawley rats were divided into young control (YC), aged control (AC), and COR (5, 10, and 20 mg/kg) treated aged rat groups. Aging-associated serum biochemical changes and inflammatory parameters were analyzed by biochemical assay kits, Western blotting, and real-time RT-PCR. Results showed a significant (p < 0.05) alteration in the total blood cell count, lipid metabolism, and liver functional parameters in AC group when compared with YC group. However, COR-treated aged rats ameliorated the altered biochemical parameters significantly (p < 0.05 and p < 0.01 at 5, 10, and 20 mg/kg, respectively). Furthermore, the increase in the expression of inflammatory mediators (COX-2, interleukin (IL)-6, IL-1β, and tissue necrosis factor-alpha) in aged rat testis was significant (p < 0.05) when compared with YC group. Treatment with COR at 20 mg/kg to aged rats attenuated the increased expression of inflammatory mediators significantly (p < 0.05). Mechanistic studies revealed that the potential attenuating effects exhibited by COR in aged rats was mediated by regulation of NF-κB activation and MAPKs (c-Jun N-terminal kinase, extracellular signal-regulated kinase 1/2, and p38) signaling. In conclusion, COR restored the altered serum biochemical parameters in aged rats and ameliorated the aging-associated testicular inflammation proving the therapeutic benefits of COR targeting inflammaging-associated male sexual dysfunctions.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the Korean Society of Mycology.

Entities:  

Keywords:  Cordyceps militaris; MAPKs; cytokines; inflammaging; interleukin; testicular damage

Year:  2022        PMID: 35291597      PMCID: PMC8890559          DOI: 10.1080/12298093.2022.2035515

Source DB:  PubMed          Journal:  Mycobiology        ISSN: 1229-8093            Impact factor:   1.858


Introduction

Aging is an unavoidable phenomenon of life attributed with severe changes in the different levels from molecules to organs, which carries a possibility of accelerating several aging-related diseases (ARDs) [1,2]. Aging and inflammation also termed as “inflammaging” is an interconnected network with steady development of the inflammatory state in elderly population affecting various organ systems. Inflammaging in male reproductive function covers a wide variety of problems including erectile dysfunction, premature or delayed ejaculation, and a decline of sexual desire ultimately leading to male infertility [3,4]. Many of these changes can be related to or exacerbated by aging-associated inflammatory responses [5,6]. As the life expectancy has been steadily improving, men are seeking to preserve their sexuality and sexual potency into old age. Mounting evidence indicated that pro- and anti-inflammatory molecules and their imbalance contribute to fundamental mechanisms of aging [7,8]. The presence of abnormal and increasing inflammatory molecules in the male reproductive tissues might affect the male physiological sexual functions and become highly detrimental in sperm production [9]. Therefore, it is reasonable to assume that inflammation is usually implicated in the testicular aging process. Although, the impact of anti-inflammatory agents, caloric restriction, and long-term physical exercise on improving the elderly men health status were highlighted [1], the current knowledge on the inflammaging in male reproductive tract and development of appropriate therapeutic anti-inflammaging agents that can help in mitigating male sexual dysfunctions and testicular damage is still unclear [10]. Cordycepin (3′-deoxyadenosine), a purine nucleoside derivative is the main functional component of an entomopathogenic fungus, Cordyceps militaris (Linn.) Fr., used extensively as a crude drug in traditional Oriental medicine and as a folk tonic food in East Asian countries [11,12]. Cordycepin has been known to exhibit many pharmacological properties, including antitumor, antifungal, antiviral, anti-inflammatory, antiatherosclerotic, antioxidant, antiaging, and anticancer and has an ability to enhance immune functions [13-16]. Furthermore, the anti-inflammatory potential of C. militaris and its active constituent cordycepin in lipopolysaccharide (LPS)-stimulated macrophages, inflammatory-associated diabetes regulating genes, and neuroinflammation was also documented [17-20]. Recently, the therapeutic potential of cordycepin as a strong antiviral agent against proteins with SARS-CoV-2 and in the treatment of COVID-19 has been reported [21,22]. Reports from our laboratory and others also revealed that cordycepin enhances sexual function and ameliorates age-related oxidative stress-mediated testicular dysfunction by restoring the antioxidative enzyme status [23-26]. However, the protective effects of cordycepin in inflammaging-associated testicular damage have not been elucidated. Thus, in the present study, we investigated the effects of cordycepin in ameliorating inflammatory responses in the testes of naturally aged rats and explored the underlying mechanisms. In addition, the effect of cordycepin on aging-mediated biochemical changes in blood chemistry parameters was also evaluated.

Materials and methods

Chemicals

Cordycepin (Figure 1(a)) was isolated from C. militaris and purified by butanol partition, silica gel flash chromatography, and recrystallization to obtain 99.5% pure compound named “COR” as reported previously [26]. All chemicals and reagents were purchased from Santa Cruz Biotechnology, Dallas, TX.
Figure 1.

Effect of COR on body weight increments. (a) Structure of cordycepin; (b) Total body weight increments during the course of the study in YC, AC, COR-5, COR-10, and COR-20 groups. Each point represents the mean ± SD (n = 10). ###p < 0.001 compared with YC group. YC: young control, AC: aged control, COR-5: aged rats plus cordycepin 5 mg/kg treated group, COR-10: aged rats plus cordycepin 10 mg/kg treated group and COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Effect of COR on body weight increments. (a) Structure of cordycepin; (b) Total body weight increments during the course of the study in YC, AC, COR-5, COR-10, and COR-20 groups. Each point represents the mean ± SD (n = 10). ###p < 0.001 compared with YC group. YC: young control, AC: aged control, COR-5: aged rats plus cordycepin 5 mg/kg treated group, COR-10: aged rats plus cordycepin 10 mg/kg treated group and COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Experimental animals and design

Fifty Sprague Dawley rats (40 rats, 14-month-old 650 ± 20 g and 10 rats, 2-month-old 280 ± 20 g), were obtained from Hanil Experimental Animal Breeding Co. Ltd. (Yeumsung, Chungbuk, Korea), and were maintained at specific pathogen-free animal facility, Regional Innovation Center, Konkuk University, Republic of Korea. Animals were acclimatized at a constant temperature (23 ± 2 °C) and relative humidity (55 ± 10%) on a 12/12-h light/dark cycle for at least 1 week prior to the experiments providing with standard pellet diet and water ad libitum. For experiments, rats were randomly divided into five groups (n = 10): the young control (YC) and aged control (AC) groups received only vehicle (distilled water), whereas the COR-treated groups (COR-5, COR-10, and COR-20) were administrated orally after pelletization at daily doses of 5, 10, and 20 mg/kg body weight of COR, respectively for 6 months. The selection of doses and administration procedures were performed based on our previous study [26]. At the end of the experiment schedule and overnight fasting (only water was provided ad libitum), the animals were sacrificed with carbon dioxide following the National Institutes of Health (NIH) guidelines. The YC group was 8 months old and AC/COR groups were 20 months old at the time of sacrifice. The body weight increments during the course of the study were monitored and testes of each rat were isolated after the experiment removing any adhering adipose tissue. A 10% homogenate of the testis tissue was prepared in Tris-HCl buffer (0.1 M, pH 7.4), centrifuged (2500 rpm for 10 min at 4 °C) to pellet the cell debris, and the clear supernatant was used for Western blotting and other biochemical assays. All animal experiments were performed in accordance with the Institutional Animal Care and Use Committee guidelines of Konkuk University, and the study was approved by the Animal Ethics Committee in accordance with the 14th article of the Korean Animal Protection Law.

Blood chemistry panels

To measure the blood chemistry parameters, blood samples were collected from the abdominal vein in a SST® gel & clot activator tube (Becton and Dickinson, Franklin Lakes, NJ, USA). Serum was separated by centrifugation at 1500 × g for 10 min at room temperature. An automated chemistry analyzer (Hitachi-747, Hitachi Medical Co., Tokyo, Japan) was used to measure serum biochemical parameters association with lipid metabolism and liver functions including the aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), glutamyl transpeptidase (γ-GTP), albumin (Alb), total cholesterol (T-Cho), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), and low-density lipoprotein-cholesterol (LDL-C). A part of blood was collected in a test tube containing ethylenediaminetetraacetic acid (EDTA) (Vacutainer K3E, BD Biosciences, Plymouth, UK) as an anticoagulant to measure the number of blood cell and analyzed using an automated blood cell analyzer (Sysmex NE-8000, TOA Medical Electronics, Kobe, Japan).

Western blot analysis

The procedure for protein expression analysis was followed by Western blotting technique as described earlier [27]. Briefly, testis protein from each samples were separated by 10% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA). Each membrane was incubated for 1 h in Tris-buffered saline containing 0.1% Tween-20 and 5% skim milk to block nonspecific binding. The membranes were then incubated with specific primary antibodies (1:1000 dilution; Santa Cruz Biotechnology, Dallas, TX, USA) against inflammatory mediators. The proteins were detected using horseradish peroxidase-conjugated secondary antibodies and a chemiluminescence detection system (GE Healthcare Life Sciences, Little Chalfont, UK). The internal control used was β-actin and the intensity was analyzed using the ImageJ software package (version 1.41o; National Institutes of Health, NIH, Bethesda, MD, USA).

Reverse transcription-polymerase chain reaction

RNABee reagent (AMS Bio, Abingdon, UK) was used to extract the total RNA according to the manufacturer’s instructions, and 1 µg of extracted RNA was reverse-transcribed as previously described [28]. Polymerase chain reaction (PCR) was performed as described in our previous report [27], and the primers used for the study are shown in Table 1. Band intensities were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) band analyzed by NIH ImageJ software (version 1.41o; National Institutes of Health, Bethesda, MD).
Table 1.

Primers used in the study.

GeneOligonucleotide sequence (5′–3′)
IL-1βForward: 5′-AGG CTG ACA GAC CCC AAA AG-3′
Reverse: 5′-CTC CAC GGG CAA GAC ATA GG-3′
IL-6Forward: 5′-GAA ATG ATG GAT GCT TCC AAA CTG G-3′
Reverse: 5′-GGA TAT ATT TTC TGA CAC AGT GAG G-3′
TNF-αForward: 5′-ACT CCC AGA AAA GCA AGC AA-3′
Reverse: 5′-CGA GCA GGA ATG AGA AGA GG-3′
COX-2Forward: 5′-GTG GAA AAG CCT CGT CCA GA-3′
Reverse: 5′-TCC TCC GAA GGT GCT AGG TT-3′
GAPDHForward: 5′-GTT ACC AGG GCT GCC TTC TC-3′
Reverse: 5′-GAT GGT GAT GGG TTT CCC GT-3′

IL, interleukin; TNF-α, tissue necrosis factor-alpha; COX-2, cyclooxegenase-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Primers used in the study. IL, interleukin; TNF-α, tissue necrosis factor-alpha; COX-2, cyclooxegenase-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Statistical analysis

The results are expressed as the mean ± standard deviation (SD). Statistical significance was analyzed by one-way analysis of variance (ANOVA) followed by Tukey’s post hoc test for multiple comparisons using the Graph-Pad prism software package (version 6.0; GraphPad, Inc., La Jolla, CA) for Windows. A value of p < 0.05 was considered statistically significant.

Results

Effect of COR on body weight increments

The changes in body weight gain in all the groups during the course of experiment were observed on a monthly basis. The body weights of the aged rats were significantly higher compared with the young rats (p < 0.001), which is seen as a normal growth pattern and might be considered as an indicator of aging. However, in COR-treated aged rat groups (5, 10, and 20 mg/kg), the body weight gain was lower when compared with untreated AC group but the changes were not significant (Figure 1(b); Supplementary Table S1).

Effect of COR on the blood chemistry panels

As shown in Table 2, the numbers of red blood cell (RBC) and white blood cell (WBC) were decreased significantly (p < 0.01) to more than 10% in AC group when compared with YC group. Although the platelet count in AC rats was also markedly decreased when compared with YC group, the results were not significant. In particular, significant changes in the subtypes of WBC were displayed in aged rats. Aging significantly increased the percentage of neutrophil (p < 0.05), eosinophil (p < 0.01), lymphocyte (p < 0.05), and monocyte (p < 0.05) in YC group. COR treatment (5, 10, and 20 mg/kg) to aged rats significantly improved the RBC count and was found to be nearly normal level in COR-20 group (p < 0.01). However, COR treatment did not influence the WBC count. In addition, the altered subtypes of WBC in AC group were considerably recovered by the administration of COR at all doses (5, 10, and 20 mg/kg). However, significant effect was observed in recovering the altered neutrophil (p < 0.5), eosinophil (p < 0.01), lymphocyte (p < 0.05), and monocytes (p < 0.05) with COR treated at 20 mg/kg dose in aged rats.
Table 2.

Effect of COR on the blood chemistry panels.

GroupRBC (×106/µL)WBC (×103/µL)NEUT (%)EOS (%)BASO (%)LYMP (%)MONO (%)PLT (×106/µL)
YC9.5 ± 0.38.2 ± 3.742.6 ± 5.04.7 ± 1.72.2 ± 0.630.4 ± 1.72.3 ± 0.3867.0 ± 65.9
AC8.5 ± 0.3##6.9 ± 1.6##60.4 ± 10.6#12.3 ± 3.5##1.9 ± 0.439.2 ± 5.1#4.0 ± 1.2#829.8 ± 136.4
COR-59.0 ± 0.4*6.2 ± 0.857.6 ± 4.48.4 ± 3.31.9 ± 0.534.9 ± 6.23.9 ± 1.0896.0 ± 231.0
COR-109.3 ± 0.6*6.3 ± 2.255.0 ± 3.06.9 ± 2.3*1.8 ± 0.533.5 ± 6.33.5 ± 0.6846.1 ± 220.0
COR-209.4 ± 0.5**6.6 ± 1.144.1 ± 4.0*6.2 ± 2.9**1.7 ± 0.530.9 ± 5.7*2.6 ± 1.1*857.3 ± 174.3

Data are expressed in mean ± SD. YC: young control, AC: old control, COR-5: cordycepin (5 mg/kg) treated old rats, COR-10: cordycepin (10 mg/kg) treated old rats, COR-20: cordycepin (20 mg/kg) treated old rats, RBC; red blood cell, WBC; white blood cell, NEUT; neutrophil, EOS; eosinophil, BASO; basophil, LYMPH; lymphocyte, MONO; monocyte, PLT; platelet.

p < 0.05 and ##p < 0.01 compared with YC group.

p < 0.05 and **p < 0.01 compared with AC group.

Effect of COR on the blood chemistry panels. Data are expressed in mean ± SD. YC: young control, AC: old control, COR-5: cordycepin (5 mg/kg) treated old rats, COR-10: cordycepin (10 mg/kg) treated old rats, COR-20: cordycepin (20 mg/kg) treated old rats, RBC; red blood cell, WBC; white blood cell, NEUT; neutrophil, EOS; eosinophil, BASO; basophil, LYMPH; lymphocyte, MONO; monocyte, PLT; platelet. p < 0.05 and ##p < 0.01 compared with YC group. p < 0.05 and **p < 0.01 compared with AC group.

Effect of COR on serum biochemical parameters related to liver function

With respect to the serum biochemistry parameters associated with liver functions, AC group showed marked alterations when compared with YC group with exception of Alb levels (Table 3). Significant changes were observed in parameters including the AST (p < 0.01), ALT (p < 0.05), ALP (p < 0.05), and γ-GTP (p < 0.05) between YC and AC groups. However, COR (5, 10, and 20 mg/kg) treatment to aged rats ameliorated the altered levels of liver function marker enzymes when compared with AC group. Although we observed a dose-dependent effect with COR (5, 10, and 20 mg/kg) in all the parameters tested, a significant effect was shown by COR treated at 20 mg/kg dose in recovering the parameters related to liver function in aged rats (p < 0.01 for AST and ALT; p < 0.05 for ALP and γ-GTP, respectively).
Table 3.

Effect of COR on serum biochemical parameters related to liver function.

GroupAlb (g/dL)AST (U/L)ALT (U/L)ALP (U/L)γ-GTP (U/L)
YC4.2 ± 0.4138.4 ± 75.189.5 ± 7.1113.8 ± 12.42.2 ± 4.1
AC4.1 ± 0.2351.8 ± 72.9##179.9 ± 37.7#176.3 ± 75.1#7.8 ± 6.5#
COR-54.0 ± 0.3255.7 ± 72.8*105.2 ± 72.2*164.6 ± 30.73.4 ± 1.2
COR-104.3 ± 0.3242.4 ± 102.1*102.4 ± 80.9*167.3 ± 50.42.7 ± 0.6*
COR-204.1 ± 0.4198.0 ± 64.6**93.7 ± 80.8**148.0 ± 28.0*2.5 ± 1.9*

Data are expressed in mean ± SD. YC: young control, AC: old control, COR-5: cordycepin (5 mg/kg) treated old rats, COR-10: cordycepin (10 mg/kg) treated old rats, COR-20: cordycepin (20 mg/kg) treated old rats, Alb; albumin, AST; aspartate aminotransferase, ALT; alanine aminotransferase, ALP; alkaline phosphatase, γ-GTP; gamma-glutamyl transpeptidase.

p < 0.05 and ##p < 0.01 compared with YC group.

p < 0.05 and **p < 0.01 compared with AC group.

Effect of COR on serum biochemical parameters related to liver function. Data are expressed in mean ± SD. YC: young control, AC: old control, COR-5: cordycepin (5 mg/kg) treated old rats, COR-10: cordycepin (10 mg/kg) treated old rats, COR-20: cordycepin (20 mg/kg) treated old rats, Alb; albumin, AST; aspartate aminotransferase, ALT; alanine aminotransferase, ALP; alkaline phosphatase, γ-GTP; gamma-glutamyl transpeptidase. p < 0.05 and ##p < 0.01 compared with YC group. p < 0.05 and **p < 0.01 compared with AC group.

Effect of COR on serum biochemical parameters related to glucose and lipid metabolism

Aging significantly decreased the glucose level and increased the T-Cho and TG levels in AC group when compared with YC group (p < 0.05). Treatment with COR to aged rats ameliorated these changes with a significant recovery observed in glucose and TG levels treated at 20 mg/kg (p < 0.05). In addition, the HDL-C and LDL-C contents deviated from the levels in YC group with aging but did not show significant differences. However, COR treatment (5, 10, and 20 mg/kg) to aged rats showed improved HDL-C and LDL-C levels when compared with AC group (p < 0.01 at COR 20 mg/kg). Interestingly, the improved levels were found to be superior to the levels observed in YC group (Table 4).
Table 4.

Effect of COR on serum biochemical parameters related to glucose and lipid metabolism.

GroupGlu (mg/dL)T.Cho (mg/dL)TG (mg/dL)HDL-C (mg/dL)LDL-C (mg/dL)
YC180.2 ± 22.084.0 ± 17.185.6 ± 17.323.9 ± 3.06.9 ± 1.6
AC132.5 ± 28.9#115.6 ± 19.1#117.5 ± 24.9#19.3 ± 3.69.4 ± 1.8
COR-5157.4 ± 22.5102.1 ± 12.8107.8 ± 39.425.3 ± 4.26.2 ± 1.4*
COR-10159.2 ± 28.2101.5 ± 30.299.0 ± 13.426.4 ± 2.0*4.5 ± 1.6**
COR-20172.4 ± 27.7*99.0 ± 21.284.7 ± 12.1*29.5 ± 1.3**5.0 ± 1.1**

Data were expressed in mean ± SD. YC: young control, AC: old control, COR-5: cordycepin (5 mg/kg) treated old rats, COR-10: cordycepin (10 mg/kg) treated old rats, COR-20: cordycepin (20 mg/kg) treated old rats, Glu; glucose, T.Cho; total cholesterol, TG; triglyceride, HDL-C; high density lipoprotein-cholesterol, LDL-C; low density lipoprotein-cholesterol.

p < 0.05 and ##p < 0.01 compared with YC group.

p < 0.05 and **p < 0.01 compared with AC group.

Effect of COR on serum biochemical parameters related to glucose and lipid metabolism. Data were expressed in mean ± SD. YC: young control, AC: old control, COR-5: cordycepin (5 mg/kg) treated old rats, COR-10: cordycepin (10 mg/kg) treated old rats, COR-20: cordycepin (20 mg/kg) treated old rats, Glu; glucose, T.Cho; total cholesterol, TG; triglyceride, HDL-C; high density lipoprotein-cholesterol, LDL-C; low density lipoprotein-cholesterol. p < 0.05 and ##p < 0.01 compared with YC group. p < 0.05 and **p < 0.01 compared with AC group.

Effect of COR on aging mediated inflammatory cytokine expression in rat testis

The protein and mRNA expression of inflammatory mediators including COX-2, IL-1β, IL-6, and TNF-α and their corresponding quantification data are shown in Figures 2 and 3, respectively. The protein expression of cyclooxegenase-2 (COX-2), interleukin (IL)-1β, IL-6, and tissue necrosis factor-alpha (TNF-α) were increased in the testis of AC groups when compared with the YC group. However, treatment with COR at 20 mg/kg attenuated the increased protein expression when compared with AC group (Figure 2(a)). Quantification data revealed a marked increase in protein level in AC group when compared with YC group and this increase was significantly (p < 0.01) reversed by COR (Figure 2(b); Supplementary Table S2). The mRNA expression and the corresponding quantification data showed a similar pattern (Figure 3(a,b); Supplementary Table S3).
Figure 2.

Effect of COR on protein expression levels of inflammatory markers. (a) Protein expression of COX-2, IL-1β, IL-6, and TNF-α in YC, AC, and COR-20 groups analyzed by Western blotting in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. β-Actin was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. COX-2: cyclooxegenase-2, IL: interleukin, TNF-α: tumor necrosis factor-α, YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Figure 3.

Effect of COR on the mRNA expression levels of inflammatory markers. (a) mRNA expression of COX-2, IL-1β, IL-6, and TNF-α analyzed by RT-PCR analysis in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. GAPDH was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. COX-2: cyclooxegenase-2, IL: interleukin, TNF-α: tumor necrosis factor-α, YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Effect of COR on protein expression levels of inflammatory markers. (a) Protein expression of COX-2, IL-1β, IL-6, and TNF-α in YC, AC, and COR-20 groups analyzed by Western blotting in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. β-Actin was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. COX-2: cyclooxegenase-2, IL: interleukin, TNF-α: tumor necrosis factor-α, YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group. Effect of COR on the mRNA expression levels of inflammatory markers. (a) mRNA expression of COX-2, IL-1β, IL-6, and TNF-α analyzed by RT-PCR analysis in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. GAPDH was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. COX-2: cyclooxegenase-2, IL: interleukin, TNF-α: tumor necrosis factor-α, YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Effect of COR on aging mediated NF-κB signaling in rat testis

Compared with the YC group, the protein expression of phosphorylated IκB-α, IκB kinase-α (IKK-α), and nuclear factor-κB (NF-κB) were increased in AC group. COR (20 mg/kg) treated aged rats showed a marked decrease in phospo (p)-IκB-α, p-IKK-α, and NF-κB expression (Figure 4(a)) when compared with AC group. Quantification data indicated that the relative intensities of p-IκB-α, p-IKK-α, and NF-κB were increased when compared to YC group, but significant (p < 0.05) increase was observed only in p-IκB-α and NF-κB molecules (Supplementary Table S4). COR treatment to aged rats showed significant (p < 0.05) reduction in the increased levels of p-IκB-α and NF-κB expression (Figure 4(b)). Although the expression of p-IKK-α was slightly decreased when compared with AC group, the values were not significant. Furthermore, there were no significant changes in the expression level of IκB/α, and IKK-α between the YC, AC, and COR-20 groups.
Figure 4.

Effect of COR on expression of NF-κB-mediated inflammatory responses. (a) Protein expression of phospho-IκB-α, IκB-α, phospho-IKK-α, IKK-α, and NF-κB in YC, AC, and COR-20 groups analyzed by Western blotting in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. β-Actin was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. NF-κB: nuclear factor-κB, IKK-α: IκB kinase-α, IκB-α: NF-κB inhibitor-α, YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Effect of COR on expression of NF-κB-mediated inflammatory responses. (a) Protein expression of phospho-IκB-α, IκB-α, phospho-IKK-α, IKK-α, and NF-κB in YC, AC, and COR-20 groups analyzed by Western blotting in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. β-Actin was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. NF-κB: nuclear factor-κB, IKK-α: IκB kinase-α, IκB-α: NF-κB inhibitor-α, YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group.

Effect of COR on aging mediated inflammatory MAPK signaling in rat testis

To understand the mechanistic pathway involved in the protective effect of COR in aging-mediated testicular inflammation, we further assessed the mitogen-activated protein kinase (MAPK) signaling expression including the c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 MAPKs, in testis of aged rats by detecting their phosphorylated forms by Western blot analysis using respective phospho-specific antibodies (Figure 5(a)). Compared with YC group, the expression of these molecules was increased in AC group. Results showed that the aging-associated inflammatory responses strongly enhanced the phosphorylation of all the three MAPKs tested (p-JNK, p-ERK, and p-p38 MAPKs). However, COR (20 mg/kg) treated aged rats ameliorated the increased expression. Quantification data revealed a marked reduction in the increased expression of these molecules with significant (p < 0.05) levels observed with p-ERK, and p-p38 MAPKs (Supplementary Table S5). Although the increased p-JNK expression observed in AC rats was reduced in COR-20 group, the values were not significant (Figure 5(b)). Furthermore, there were no significant changes in the expression level of JNK, ERK, and p38 MAPKs between the YC, AC, and COR-20 groups.
Figure 5.

Effect of COR on MAPKs-mediated inflammatory signaling. (a) Protein expression of phospho-JNK, JNK, phospho-ERK1/2, ERK1/2, phospho-p38, and p38 MAPKs in YC, AC, and COR-20 groups analyzed by Western blotting in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. β-Actin was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group, p-JNK: phospho-c-Jun N-terminal kinase, ERK: extracellular signal-regulated kinase, p-38 MAPK: p38 mitogen-activated protein kinase.

Effect of COR on MAPKs-mediated inflammatory signaling. (a) Protein expression of phospho-JNK, JNK, phospho-ERK1/2, ERK1/2, phospho-p38, and p38 MAPKs in YC, AC, and COR-20 groups analyzed by Western blotting in rat testis tissue; (b) Relative intensity levels (fold) in three independent experiments, respectively. β-Actin was used as an internal control. The data are expressed as the mean ± SD. #p < 0.05 compared with YC and *p < 0.05 compared with AC group. YC: young control, AC: aged control, COR-20: aged rats plus cordycepin 20 mg/kg treated group, p-JNK: phospho-c-Jun N-terminal kinase, ERK: extracellular signal-regulated kinase, p-38 MAPK: p38 mitogen-activated protein kinase.

Discussion

It is well understood that there is an accelerated inflammatory condition and imbalance in inflammatory homeostasis with increase in age. Aging and inflammation the two closely related processes termed as “inflammaging” can affect multi-organ system contributing to the pathogenesis of various ARDs including the dysfunction in male reproductive system [29,30]. Although decrease in sexual libido and desire can be considered normal during aging process, the impact of inflammaging in male reproductive tract might enhance the sexual problems causing erectile dysfunction, premature ejaculation, impotence, and testicular damage [31,32]. Since the processes of inflammaging are low grade, chronic, and micro-inflammatory in nature, extensive research has been done to identify a potential therapeutic agent in attenuating the inflammaging process in male reproductive system. Delaying the aging of the testis and improving the physiological sexuality in aged men is an important strategy as the testis is the major organ in spermatogenesis. Earlier report indicated that rats with age range from 6 to 12 months (∼30 years of human age) can be considered as young adults and rats with age range 20–30 months (∼60–75 years of human age) as aged rats [33]. Therefore, in the present study, we used the young control (8 months old) and naturally aged rats (20 months old) to study the effects of COR by evaluating various biochemical aspects. COR-treated aged rats significantly decreased the body weight gain compared with untreated aged rats. Although the changes in body weights might not be considered as potential markers in aging, our observations might support the earlier study that COR possess hypolipidemic and antiadipogenic effects thereby aiding in maintaining the body weights in COR-treated aged rats [34]. Previous studies revealed that aging and inflammation alters the blood cell counts significantly with decreased levels of RBC, WBC, and platelets. Alternatively, elevated levels of almost all subtypes of WBC counts, including eosinophils, monocytes, neutrophils, and lymphocyte were observed [35-37]. In agreement, in the present study, aged rat groups showed decreased RBC, WBC, and platelet count compared with young rats. The WBC subtypes including eosinophils, neutrophils, monocytes, and lymphocytes were elevated in aged rats compared with YC rats. COR treatment alleviated the decreased RBC count significantly but did not show significance in the WBC and platelet count. In general, adult populations show an increased level of WBC and neutrophil count during inflammatory states [38]. However, aged and geriatric patients did not develop an increase in WBC count during inflammatory conditions, which might be due to the misadapted response of the immune system [39]. WBC count, a biomarker of immunological function, is reduced under cardiovascular diseases, smoking, and obesity [40,41]. In the present study, COR treatment to aged rats improved dose-dependently the increased neutrophil count when compared with AC group. The increased eosinophil, lymphocyte, and monocyte counts caused by aging were also reduced. Accordingly, cordycepin is expected to boost immunological function of the elderly people. The physiological aging of liver is low in comparison with other organs due to its immense regeneration capacity. However, studies indicated that older individuals develop increased liver enzymes and these changes are associated with increasing risk of cardiovascular mortality [42]. Normal levels to slight decrease in serum albumin and elevated levels of AST, ALT, ALP, and γ-GTP were observed with aging [43]. Furthermore, aging and inflammation together elevate liver enzymes and attenuate liver functions thereby accelerating the onset of various liver diseases [44]. In the present study, the liver enzyme (AST, ALT, ALP, and γ-GTP) levels in aged rats were significantly increased in agreement with the reported literature. In the conditions of low-grade chronic inflammation in aging, altered glucose and lipid metabolism was also observed [45]. In the present study, COR improved the altered parameters associated with lipid metabolism suggesting that COR successively recovers liver functions in aged rats. In the blood chemistry panels and serum biochemical profile evaluations, although we observed a dose-dependent effect at 5, 10, and 20 mg/kg, significant values were observed in all parameters tested with COR treated at 20 mg/kg (COR-20 group). Therefore, COR at 20 mg/kg dose was used to study the effects on aging-associated inflammatory responses in the testis of aged rats. Chronic low-grade inflammation is thought to be a determinant of the aging, and age-related increase in the systemic levels of several gerokines such as chemokines and cytokines was observed when compared with young individuals [46,47]. Upregulation of COX-2 expression induced by IL-1β and its receptors in testicular cells and increased COX-2 mRNA levels in Norway rat Leydig cells was reported [48,49]. Age-related decline of male reproductive functions was directly linked to the upregulation of IL-1β, TNFα, and prostaglandins [50]. In the present study, there is a significant increase in the inflammatory mediators and the proinflammatory cytokine such a COX-2, IL-1β, IL-6, and TNF-α in aged control rat testes when compared with young controls that are predicted to contribute to the inflammaging. COR treatment (20 mg/kg) to aged rats significantly attenuated the aging-associated inflammatory responses by restoring the excessive inflammatory cytokines production in comparison with aged control rats. Our results are in agreement with earlier reported works that ginsenoside Rg1 and a traditional Chinese herbal formula (Liuweidihuang Pills) inhibited the increased levels of proinflammatory cytokines and alleviated inflammation in aged testicular tissues in experimental aged mice and rats [51,52]. The NF-κB signaling pathway and its activation by inflammatory stresses in various tissues has been proposed to be one of the key mediators of aging and associated with several ARDs. NF-κB is a family of transcription factors implicated in numerous stress responses including male testicular cell death [53]. NF-κB activation accelerates the release of proinflammatory molecules, which was observed in aged rats. Earlier report indicated that regulation of NF-κB activity can be helpful in counteracting testicular stress thereby preserving testicular function in aged mice [54]. NF-κB exists in the cytoplasm with IκBα in an inactive state. During aging IKK (IκB kinase) is activated, resulting in the IKKβ-mediated phosphorylation of IκBα. Phosphorylated IκBα is subsequently ubiquitinated and degraded, leading to release and activation of NF-κB complex [55]. NF-κB is then transferred from the cytoplasm to the nucleus, where it induces the expression of downstream proinflammatory factors genes such as IL-1, IL-6, and TNF-α [56,57]. In this study, the expression of NF-κB and phosphorylation of IκB-α increased in aged rat groups and COR treatment to aged rats significantly inhibited the activation of NF-κB and phosphorylation of IκB-α expression indicating that COR might play a potential role in inhibitive proinflammatory activations via the NF-κB signaling system. MAPKs have been shown to play important roles in inflammation-associated ARDs mediating the inhibition of cell proliferation or cell death. The sub-families including the JNK, ERK, and the p38 MAPKs were activated by mitogens, stress response, and inflammatory cytokines [58,59]. MAPKs have shown to decline the function of male reproductive system by negatively affecting the spermatogenesis, sperm maturation and activation, capacitation, acrosome reaction ultimately reducing the semen quality and fertility [60]. Previous reports indicated that the sperm development in mammalian testis is regulated by MAPKs and abnormal activation of MAPKs can dysfunction Sertoli cells and affect the germ cell development [61]. Furthermore, activation of MAPKs by reproductive toxicants including the bisphenol A, 1–3-dinitrobenzene and 4-nonylphenol isomers in Sertoli TM4 cells was observed [62-64]. Furthermore, reduced ERK and p38 MAPK activities were observed in brains of aged animals and MAPKs signaling is involved in neuronal damage in aged rat brain tissues [65]. MAPKs activity was also involved in dermal inflammaging induced by particulate matter in human keratinocytes and fibroblasts [66]. In the present study, significant increase in the MAPKs expression including the JNK, ERK1/2, and p38 MAPK phosphorylation levels was shown in the testis of aged rats. However, treatment with COR (20 mg/kg) ameliorated these changes indicating that COR might regulate the increase in MAPKs activities thereby increase the reproductive success in aged rats.

Conclusions

The present study showed that long-term administration of COR improved the serum biochemical parameters in aged rats and attenuated aging-associated testicular inflammatory responses via regulating the NF-κB/MAPKs signaling pathways indicating its potential benefits in inflammaging-mediated testicular and male sexual dysfunctions. Click here for additional data file.
  63 in total

Review 1.  Aging and liver disease.

Authors:  In Hee Kim; Tatiana Kisseleva; David A Brenner
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

Review 2.  On the immunological theory of aging.

Authors:  Tamas Fulop; Jacek M Witkowski; Graham Pawelec; Cohen Alan; Anis Larbi
Journal:  Interdiscip Top Gerontol       Date:  2014-05-13

3.  Inflammation and coronary artery disease.

Authors:  R W Alexander
Journal:  N Engl J Med       Date:  1994-08-18       Impact factor: 91.245

Review 4.  White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease.

Authors:  Nicholas G Kounis; George D Soufras; Grigorios Tsigkas; George Hahalis
Journal:  Clin Appl Thromb Hemost       Date:  2014-04-24       Impact factor: 2.389

Review 5.  Male accessory gland infection.

Authors:  W Krause
Journal:  Andrologia       Date:  2008-04       Impact factor: 2.775

6.  The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival.

Authors:  X Wang; J L Martindale; Y Liu; N J Holbrook
Journal:  Biochem J       Date:  1998-07-15       Impact factor: 3.857

7.  Effects of Ageing on the Immune System: Infants to Elderly.

Authors:  R Valiathan; M Ashman; D Asthana
Journal:  Scand J Immunol       Date:  2016-04       Impact factor: 3.487

8.  Quantitative histological analysis and ultrastructure of the aging human testis.

Authors:  Huan Jiang; Wei-Jie Zhu; Jing Li; Qiu-Ju Chen; Wei-Bo Liang; Yi-Qun Gu
Journal:  Int Urol Nephrol       Date:  2013-11-26       Impact factor: 2.370

9.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

Review 10.  The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.

Authors:  Claudio Franceschi; Paolo Garagnani; Cristina Morsiani; Maria Conte; Aurelia Santoro; Andrea Grignolio; Daniela Monti; Miriam Capri; Stefano Salvioli
Journal:  Front Med (Lausanne)       Date:  2018-03-12
View more
  1 in total

1.  Effects of Cordyceps militaris fermentation products on reproductive development in juvenile male mice.

Authors:  Shan Lin; Wen-Kuang Hsu; Ming-Shiun Tsai; Tai-Hao Hsu; Tso-Ching Lin; Hong-Lin Su; Sue-Hong Wang; Dazhi Jin
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.